Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices

被引:20
|
作者
Asleh, Rabea [1 ]
Alnsasra, Hilmi [1 ]
Daly, Richard C. [1 ]
Schettle, Sarah D. [1 ]
Briasoulis, Alexandros [1 ]
Taher, Riad [1 ]
Dunlay, Shannon M. [1 ]
Stulak, John M. [1 ]
Behfar, Atta [1 ]
Pereira, Naveen L. [1 ]
Frantz, Robert P. [1 ]
Edwards, Brooks S. [1 ]
Clavell, Alfredo L. [1 ]
Kushwaha, Sudhir S. [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2019年 / 8卷 / 22期
关键词
heart transplantation; left ventricular assist device; outcome; risk factors; vasoplegia; CARDIOPULMONARY BYPASS VASOPLEGIA; PRIMARY GRAFT DYSFUNCTION; RISK-FACTORS; CARDIAC-SURGERY; SHOCK; PATHOPHYSIOLOGY; VASOPRESSIN; MANAGEMENT; IMPACT;
D O I
10.1161/JAHA.119.013108
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The presence of a durable left ventricular assist device (LVAD) is associated with increased risk of vasoplegia in the early postoperative period following heart transplantation (HT). However, preoperative predictors of vasoplegia and its impact on survival after HT are unknown. We sought to examine predictors and outcomes of patients who develop vasoplegia after HT following bridging therapy with an LVAD. Methods and Results-We identified 94 patients who underwent HT after bridging with continuous-flow LVAD from 2008 to 2018 at a single institution. Vasoplegia was defined as persistent low vascular resistance requiring >= 2 intravenous vasopressors within 48 hours after HT for >24 hours to maintain mean arterial pressure >70 mm Hg. Overall, 44 patients (46.8%) developed vasoplegia after HT. Patients with and without vasoplegia had similar preoperative LVAD, echocardiographic, and hemodynamic parameters. Patients with vasoplegia were significantly older; had longer LVAD support, higher preoperative creatinine, longer cardiopulmonary bypass time, and higher Charlson comorbidity index; and more often underwent combined organ transplantation. In a multivariate logistic regression model, older age (odds ratio: 1.08 per year; P=0.010), longer LVAD support (odds ratio: 1.06 per month; P=0.007), higher creatinine (odds ratio: 3.9 per 1 mg/dL; P=0.039), and longer cardiopulmonary bypass time (odds ratio: 1.83 per hour; P=0.044) were independent predictors of vasoplegia. After mean follow-up of 4.0 years after HT, vasoplegia was associated with increased risk of all-cause mortality (hazard ratio: 5.20; 95% CI, 1.71-19.28; P=0.003). Conclusions-Older age, longer LVAD support, impaired renal function, and prolonged intraoperative CPB time are independent predictors of vasoplegia in patients undergoing HT after LVAD bridging. Vasoplegia is associated with worse prognosis; therefore, detailed assessment of these predictors can be clinically important.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Vasoplegia after pediatric cardiac transplantation in patients supported with a continuous flow ventricular assist device
    Sacks, Loren D.
    Hollander, Seth A.
    Zhang, Yulin
    Ryan, Kathleen R.
    Ford, Mackenzie A.
    Maeda, Katsuhide
    Murray, Jenna M.
    Almond, Christopher S.
    Kwiatkowski, David M.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (06) : 2433 - 2440
  • [22] Neurologic Events in Continuous-Flow Left Ventricular Assist Devices
    Kadakkal, Ajay
    Najjar, Samer S.
    CARDIOLOGY CLINICS, 2018, 36 (04) : 531 - +
  • [23] Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation
    Vest, Amanda R.
    Mistak, Stanley M.
    Hachamovitch, Rory
    Mountis, Maria M.
    Moazami, Nader
    Young, James B.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (10) : 789 - 796
  • [24] Prevalence of Cerebral Microbleeds in Patients With Continuous-Flow Left Ventricular Assist Devices
    Yoshioka, Daisuke
    Okazaki, Shuhei
    Toda, Koichi
    Murase, Sho
    Saito, Shunsuke
    Domae, Keitaro
    Miyagawa, Shigeru
    Yoshikawa, Yasushi
    Daimon, Takashi
    Sakaguchi, Manabu
    Sawa, Yoshiki
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (09):
  • [25] Physiologic effects of continuous-flow left ventricular assist devices
    Healy, Aaron H.
    McKellar, Stephen H.
    Drakos, Stavros G.
    Koliopoulou, Antigoni
    Stehlik, Josef
    Selzman, Craig H.
    JOURNAL OF SURGICAL RESEARCH, 2016, 202 (02) : 363 - 371
  • [26] Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors
    Eric E. C. de Waal
    Bas van Zaane
    Marnix M. van der Schoot
    Albert Huisman
    Faiz Ramjankhan
    Wilton A. van Klei
    Nandor Marczin
    BMC Anesthesiology, 18
  • [27] Endothelial Function in Patients With Continuous-Flow Left Ventricular Assist Devices
    Poredos, Pavel
    Jezovnik, Mateja K.
    Radovancevic, Rajko
    Gregoric, Igor D.
    ANGIOLOGY, 2021, 72 (01) : 9 - 15
  • [28] A Comprehensive Imaging Approach to Guide the Management of Patients with Continuous-Flow Left Ventricular Assist Devices
    Hannawi, Bashar
    Estep, Jerry D.
    CARDIOLOGY CLINICS, 2018, 36 (04) : 583 - +
  • [29] Clinical outcomes in sensitized heart transplant patients bridged with ventricular assist devices
    Kidambi, Sumanth
    Mohamedali, Burhan
    Bhat, Geetha
    CLINICAL TRANSPLANTATION, 2015, 29 (06) : 499 - 505
  • [30] Electrophysiologic Changes and Their Effects on Ventricular Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist Devices
    Celik, Mehmet
    Emiroglu, Mehmet Yunus
    Bayram, Zubeyde
    Izci, Servet
    Karagoz, Ali
    Akbal, Ozgur Yasar
    Kahyaoglu, Muzaffer
    Kup, Ayhan
    Yilmaz, Yusuf
    Kirali, Mehmet Kaan
    Ozdemir, Nihal
    ASAIO JOURNAL, 2022, 68 (03) : 341 - 348